Key facts
- This page summarizes Marvin L. White's Form 4 filing for Aptevo Therapeutics Inc. (APVO).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 10 Aug 2026, 21:34.
Marvin L. White - 17 Jul 2026 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)
- Reporting relationship
- Executive Chair, Director
- Issuer ticker
- APVO
- Reported as of
- 17 Jul 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Aug 2026, 21:34:08 UTC
- Prior SEC filing
- 04 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ SoYoung Kwon, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Marvin L. White filed Form 4 for Aptevo Therapeutics Inc. (APVO) on 10 Aug 2026.
Change
- Previous filing in this sequence was filed on 04 May 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001493324
Primary reporting owner
White Marvin L
- Relationship
- Executive Chair, Director
- Address
- 2401 4TH AVENUE, 1050, SEATTLE
- Signature
- /s/ SoYoung Kwon, Attorney-in-Fact
- Signature date
- 10 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
APVO
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1
- Change %
- Price
- Shares after
- 1
- Date
- 17 Jul 2026
- Ownership
- Direct
- Footnotes
- F1
APVO
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,666
- Change %
- +166600%
- Price
- Shares after
- 1,667
- Date
- 06 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
APVO
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -406
- Change %
- -24%
- Price
- $4.07*
- Shares after
- 1,261
- Date
- 06 Aug 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
APVO
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -1
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 17 Jul 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1
- Exercise price
- Footnotes
- F1, F3
APVO
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -1,666
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 06 Aug 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,666
- Exercise price
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
Footnote F2
Represents shares withheld by Issuer to satisfy tax withholding obligations on the vesting of RSUs.
Footnote F3
On July 17, 2024, the reporting person was granted 22,325 (1 post-splits) RSUs, vesting in three approximately equal annual installments beginning on July 17, 2025.
Footnote F4
On August 6, 2025, the reporting person was granted 30,000 (1,666 post-split) RSUs, vesting on the first anniversary of the date of grant.